Using the Guidelines to Increase Patient Throughput and Decrease Cost of Care
Speakers:
Phillip Levy, MD, MPH - Associate VP, Translational Science, Wayne State University
Tami Curtis, BSN, RN, SCRN, CEN, CCA - Coordinator-Quality Reporting & Analytics, Indiana University Health
Moderator:
Christina Koutras, BSN, RN, CPHQ - Director NCDR Registry Products, American College of Cardiology
Description:
The 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline is the first ever clinical guideline from the ACC and AHA to focus solely on the evaluation and diagnosis of adult patients with chest pain. Hear from an expert-- a physician on the writing committee will speak of the importance of this guideline on chest pain evaluation and diagnosis and will include how this published article helped shape the Chest Pain- MI Registry's upgraded version 3.1
Learning Objectives:
- Explore the importance of risk stratification in the evaluation of patients presenting with chest pain.
- Name two benefits of an evidence-based approach for the diagnostic workup on patients deemed to be ‘low risk’.
- Determine which type of stress testing is most appropriate for the ACS patient.